Navigation Links
Thermage, Inc. Announces Initial Shipments of Cellulite Product
Date:3/12/2008

HAYWARD, Calif., March 12 /PRNewswire-FirstCall/ -- Thermage, Inc. (Nasdaq: THRM), a leader in non-invasive tissue tightening in the aesthetic industry, today announced it has begun initial shipments of its ThermaTip(TM) CL treatment tips for use in the Company's cellulite procedure. The procedure noticeably reduces the appearance of cellulite after just a single treatment. The treatment tip and procedure are the result of 21 months of clinical and technological development and use the FDA cleared ThermaCool(R) system for the temporary improvement in the appearance of cellulite.

"We began shipments of our ThermaTip CL treatment tip on track and within the timeframe we expected," said Stephen J. Fanning, Chairman of the Board, President and Chief Executive Officer at Thermage. "Cellulite offers a new market opportunity for our Company and we expect the new tip to provide a solid contribution to our revenue in 2008."

The ThermaTip CL and cellulite procedure by Thermage incorporate the Company's patented monopolar capacitive radiofrequency technology. The advanced deep heating ThermaTip CL rebuilds collagen connective tissues and improves blood flow to the tissue helping to smooth the appearance of the skin's surface.

About Thermage

Thermage's innovative technology provides a unique non-invasive procedure designed to tighten and contour skin, significantly expanding the non-invasive aesthetic applications physicians can offer to the rapidly growing "anti- aging" market. For more information about Thermage, call 1-510-259-7117 or log on to http://www.thermage.com.

This press release may contain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 including the statement regarding revenue contribution of the cellulite treatment tip. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Thermage's actual results to differ materially from the statements contained herein including the risk that the new tip does not achieve commercial acceptance or that such acceptance is delayed, among other risks. Further information on potential risk factors that could affect Thermage's business are detailed in the Company's Form 10-Q for the period ended September 30, 2007. Undue reliance should not be placed on forward-looking statements, which speaks only as of the date they are made. Thermage undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

Results vary from subtle to dramatic. Generally improvements may be immediately visible and continue to improve for up to six months. Results are long lasting and depend on your skin condition and the aging process.


'/>"/>
SOURCE Thermage, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Thermage, Inc. Announces Fourth Quarter 2007 Results Release Date and Conference Call
2. Thermage, Inc. Appoints John F. Glenn as Chief Financial Officer
3. Thermage, Inc. Announces Distribution Agreement With Eclipse Medical, Ltd.
4. Thermage, Inc. to Present at the Maxim Group Growth Conference
5. Bradmer announces 2007 fourth quarter and fiscal year operational and financial results
6. NHP Announces Management Promotions
7. WellPoint Announces Appearances at Upcoming Conferences
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Lehman Brothers Global Healthcare Conference
9. St. Alcuin Montessori School Announces $5 Million Capital Campaign Gift
10. Hooper Holmes Announces Fourth Quarter Earnings Release Date and Conference Call Information
11. Ambulatory Services of America, Inc. Announces Joint Venture with Southern Ocean County Radiation Oncology, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent Care ... MD Now’s 28th facility overall and marks the urgent care center's eighth location in ... North of The Falls shopping mall. The new clinic offers a wide array of ...
(Date:6/23/2017)... ... ... American Farmer, will feature Chr. Hansen, Inc (CHR Hansen) in an upcoming episode ... Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your local listings for more info. ... 1874 after a groundbreaking discovery of how to industrialize enzymes. Rooted in science and ...
(Date:6/23/2017)... Chicago, IL (PRWEB) , ... June 23, 2017 ... ... insurance management assistance and financial planning services to communities in the greater Chicago ... Children’s Association to offer assistance to underprivileged youth in Chicago. , Founded in ...
(Date:6/23/2017)... ... June 23, 2017 , ... Moore Insurance, ... area with access to asset protection and financial planning services, is teaming up ... improving the lives of children with cancer and other chronic diseases. , The ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... is pleased to welcome Whipple & Company as its newest Partner Firm. Headquartered ... of balancing their clients’ risk while tailoring optimized benefit packages that strengthen the ...
Breaking Medicine News(10 mins):
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... Israel, May 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... technology which enables the functional selection of stem cells, ... for the first quarter ended March 31 st , ... our accomplishments in the first quarter of 2017," said ... quarter, we announced the treatment of the first blood ...
(Date:5/22/2017)... VALLEY COTTAGE, N.Y. , May 22, 2017 ... natural antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of ... in plain English, the results of a clinical ... after one year treatment with Gene-Eden-VIR/Novirin in individuals ... is important to note that there are no ...
Breaking Medicine Technology: